Einträge von Greil, Richard auf dem Publikationsserver
 | Eine Stufe nach oben |
Anzahl der Einträge: 10.
2023
Hart, Christina, Klamroth, Robert, Sachs, Ulrich J., Greil, Richard 
, Knoebl, Paul N., Oldenburg, Johannes, Miesbach, Wolfgang, Pfrepper, Christian , Trautmann-Grill, Karolin, Pekrul, Isabell, Holstein, Katharina, Eichler, Hermann, Weigt, Carmen, Schipp, Dorothea, Werwitzke, Sonja und Tiede, Andreas
(2023)
Emicizumab Versus Immunosuppression for Acquired Hemophilia Α (AHA).
Blood 142 (Supple), S. 2612.
Tiede, Andreas, Hart, Christina, Knöbl, Paul , Greil, Richard, Oldenburg, Johannes, Sachs, Ulrich J, Miesbach, Wolfgang, Pfrepper, Christian, Trautmann-Grill, Karolin, Holstein, Katharina, Pilch, Jan, Möhnle, Patrick, Schindler, Christoph, Weigt, Carmen, Schipp, Dorothea, May, Marcus , Dobbelstein, Christiane, Pelzer, Fabius J, Werwitzke, Sonja und Klamroth, Robert
(2023)
Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study.
The Lancet Haematology 10 (11), e913-e921.
Volltext nicht vorhanden.
, Greil, Richard, Oldenburg, Johannes, Sachs, Ulrich J, Miesbach, Wolfgang, Pfrepper, Christian, Trautmann-Grill, Karolin, Holstein, Katharina, Pilch, Jan, Möhnle, Patrick, Schindler, Christoph, Weigt, Carmen, Schipp, Dorothea, May, Marcus , Dobbelstein, Christiane, Pelzer, Fabius J, Werwitzke, Sonja und Klamroth, Robert
(2023)
Emicizumab prophylaxis in patients with acquired haemophilia A (GTH-AHA-EMI): an open-label, single-arm, multicentre, phase 2 study.
The Lancet Haematology 10 (11), e913-e921.
Volltext nicht vorhanden.
Oleshko, Olga , Werwitzke, Sonja, Klingberg, Annika, Witte, Torsten, Eichler, Hermann, Klamroth, Robert, Holstein, Katharina, Hart, Christina, Pfrepper, Christian , Knöbl, Paul , Greil, Richard , Neumeister, Peter, Reipert, Birgit M. und Tiede, Andreas
(2023)
Targets of autoantibodies in acquired hemophilia A are not restricted to factor VIII: data from the GTH-AH 01/2010 study.
Blood Advances 7 (1), S. 122-130.
Volltext nicht vorhanden.
, Werwitzke, Sonja, Klingberg, Annika, Witte, Torsten, Eichler, Hermann, Klamroth, Robert, Holstein, Katharina, Hart, Christina, Pfrepper, Christian , Knöbl, Paul , Greil, Richard , Neumeister, Peter, Reipert, Birgit M. und Tiede, Andreas
(2023)
Targets of autoantibodies in acquired hemophilia A are not restricted to factor VIII: data from the GTH-AH 01/2010 study.
Blood Advances 7 (1), S. 122-130.
Volltext nicht vorhanden.
2022
Welland, Sabrina, Leyh, Catherine, Finkelmeier, Fabian, Jefremow, André, Shmanko, Kateryna, Gonzalez-Carmona, Maria A., Kandulski, Arne, Jeliazkova, Petia, Best, Jan, Fründt, Thorben W., Djanani, Angela, Pangerl, Maria, Maieron, Andreas, Greil, Richard, Fricke, Christina, Sookthai, Disorn, Günther, Rainer, Schmiderer, Andreas, Wege, Henning, Venerito, Marino, Ehmer, Ursula, Müller, Martina, Strassburg, Christian P., Weinmann, Arndt, Siebler, Jürgen, Waidmann, Oliver, Lange, Christian M., Saborowski, Anna und Vogel, Arndt
(2022)
Real-World Data for Lenvatinib in Hepatocellular Carcinoma (ELEVATOR): A Retrospective Multicenter Study.
Liver Cancer 11 (3), S. 219-232.
Volltext nicht vorhanden.
2019
Schlenk, Richard F. , Weber, Daniela, Fiedler, Walter, Salih, Helmut R., Wulf, Gerald, Salwender, Hans, Schroeder, Thomas, Kindler, Thomas, Lübbert, Michael, Wolf, Dominik, Westermann, Jörg, Kraemer, Doris, Götze, Katharina S., Horst, Heinz-August, Krauter, Jürgen, Girschikofsky, Michael, Ringhoffer, Mark, Südhoff, Thomas, Held, Gerhard, Derigs, Hans-Günter, Schroers, Roland, Greil, Richard, Grießhammer, Martin, Lange, Elisabeth, Burchardt, Alexander, Martens, Uwe, Hertenstein, Bernd, Marretta, Lore, Heuser, Michael, Thol, Felicitas, Gaidzik, Verena I., Herr, Wolfgang, Krzykalla, Julia, Benner, Axel, Döhner, Konstanze, Ganser, Arnold, Paschka, Peter und Döhner, Hartmut
(2019)
Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD.
Blood 133 (8), S. 840-851.
Volltext nicht vorhanden.
, Weber, Daniela, Fiedler, Walter, Salih, Helmut R., Wulf, Gerald, Salwender, Hans, Schroeder, Thomas, Kindler, Thomas, Lübbert, Michael, Wolf, Dominik, Westermann, Jörg, Kraemer, Doris, Götze, Katharina S., Horst, Heinz-August, Krauter, Jürgen, Girschikofsky, Michael, Ringhoffer, Mark, Südhoff, Thomas, Held, Gerhard, Derigs, Hans-Günter, Schroers, Roland, Greil, Richard, Grießhammer, Martin, Lange, Elisabeth, Burchardt, Alexander, Martens, Uwe, Hertenstein, Bernd, Marretta, Lore, Heuser, Michael, Thol, Felicitas, Gaidzik, Verena I., Herr, Wolfgang, Krzykalla, Julia, Benner, Axel, Döhner, Konstanze, Ganser, Arnold, Paschka, Peter und Döhner, Hartmut
(2019)
Midostaurin added to chemotherapy and continued single-agent maintenance therapy in acute myeloid leukemia with FLT3-ITD.
Blood 133 (8), S. 840-851.
Volltext nicht vorhanden.
Fuchs, Michael, Goergen, Helen, Kobe, Carsten, Kuhnert, Georg, Lohri, Andreas, Greil, Richard, Sasse, Stephanie, Topp, Max S., Schäfer, Erhardt, Hertenstein, Bernd, Soekler, Martin, Vogelhuber, Martin, Zijlstra, Josée M., Keller, Ulrich Bernd, Krause, Stefan W., Wilhelm, Martin, Maschmeyer, Georg, Thiemer, Julia, Dührsen, Ulrich, Meissner, Julia, Viardot, Andreas, Eich, Hans, Baues, Christian, Diehl, Volker, Rosenwald, Andreas, von Tresckow, Bastian, Dietlein, Markus, Borchmann, Peter und Engert, Andreas
(2019)
Positron Emission Tomography–Guided Treatment in Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase III HD16 Trial by the German Hodgkin Study Group.
Journal of Clinical Oncology 37 (31), S. 2835-2845.
Volltext nicht vorhanden.
2015
Behringer, Karolin, Goergen, Helen, Hitz, Felicitas, Zijlstra, Josée M, Greil, Richard , Markova, Jana, Sasse, Stephanie, Fuchs, Michael, Topp, Max S, Soekler, Martin, Mathas, Stephan, Meissner, Julia, Wilhelm, Martin, Koch, Peter, Lindemann, Hans-Walter, Schalk, Enrico, Semrau, Robert, Kriz, Jan, Vieler, Tom, Bentz, Martin, Lange, Elisabeth, Mahlberg, Rolf, Hassler, Andre, Vogelhuber, Martin, Hahn, Dennis, Mezger, Jörg, Krause, Stefan W , Skoetz, Nicole, Böll, Boris, von Tresckow, Bastian, Diehl, Volker, Hallek, Michael, Borchmann, Peter, Stein, Harald, Eich, Hans und Engert, Andreas
(2015)
Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
The Lancet 385 (9976), S. 1418-1427.
Volltext nicht vorhanden.
, Markova, Jana, Sasse, Stephanie, Fuchs, Michael, Topp, Max S, Soekler, Martin, Mathas, Stephan, Meissner, Julia, Wilhelm, Martin, Koch, Peter, Lindemann, Hans-Walter, Schalk, Enrico, Semrau, Robert, Kriz, Jan, Vieler, Tom, Bentz, Martin, Lange, Elisabeth, Mahlberg, Rolf, Hassler, Andre, Vogelhuber, Martin, Hahn, Dennis, Mezger, Jörg, Krause, Stefan W , Skoetz, Nicole, Böll, Boris, von Tresckow, Bastian, Diehl, Volker, Hallek, Michael, Borchmann, Peter, Stein, Harald, Eich, Hans und Engert, Andreas
(2015)
Omission of dacarbazine or bleomycin, or both, from the ABVD regimen in treatment of early-stage favourable Hodgkin's lymphoma (GHSG HD13): an open-label, randomised, non-inferiority trial.
The Lancet 385 (9976), S. 1418-1427.
Volltext nicht vorhanden.
2012
d'Amore, Francesco, Leppä, Sirpa, da Silva, Maria Gomes, Relander, Thomas, De Nully Brown, Peter, Weidmann, Eckhart, Lauritzsen, Grete Fossum, Pezzutto, Antonio, Van Hoof, Achiel, van Gelder, Michel, Doorduijn, Jeanette K, Wu, Ka Lung, Kluin-Nelemans, J.C., Lugtenburg, P.J., Jankovska, Milada, Merup, Mats, Fagerli, Unn-Merete, Walewski, Jan, Hagberg, Hans, Mariz, Jose Mario, Hansen, Per Boye, Nösslinger, Thomas, Janssens, Ann, Brandefors, Lena, Demuynck, Hilde, Schaafsma, Martyn Ronald, Christiansen, Ilse, Salek, David, Jyrkkiö, Sirkku, Prochazka, Vit, Zijlstra, Josee, Böhmer, L., Greil, Richard , Stevens, Wendy, Fijnheer, Rob, van Marwijk Kooy, Marinus, Grube, Matthias, Hopfinger, Georg, Van den Neste, Eric, Jantunen, Esa, Trümper, Lorenz, Wulf, Gerald, Altmann, Bettina, Ziepert, Marita, Loeffler, Markus und Toldbod, Helle
(2012)
First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy.
Blood 120 (21), S. 57.
Volltext nicht vorhanden.
, Stevens, Wendy, Fijnheer, Rob, van Marwijk Kooy, Marinus, Grube, Matthias, Hopfinger, Georg, Van den Neste, Eric, Jantunen, Esa, Trümper, Lorenz, Wulf, Gerald, Altmann, Bettina, Ziepert, Marita, Loeffler, Markus und Toldbod, Helle
(2012)
First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy.
Blood 120 (21), S. 57.
Volltext nicht vorhanden.
Engert, Andreas, Haverkamp, Heinz, Kobe, Carsten, Markova, Jana, Renner, Christoph, Ho, Antony, Zijlstra, Josée, Král, Zdenek, Fuchs, Michael, Hallek, Michael, Kanz, Lothar, Döhner, Hartmut, Dörken, Bernd, Engel, Nicole, Topp, Max, Klutmann, Susanne, Amthauer, Holger, Bockisch, Andreas, Kluge, Regine, Kratochwil, Clemens, Schober, Otmar, Greil, Richard , Andreesen, Reinhard, Kneba, Michael, Pfreundschuh, Michael, Stein, Harald, Eich, Hans Theodor, Müller, Rolf-Peter, Dietlein, Markus, Borchmann, Peter und Diehl, Volker
(2012)
Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.
The Lancet 379 (9828), S. 1791-1799.
Volltext nicht vorhanden.
, Andreesen, Reinhard, Kneba, Michael, Pfreundschuh, Michael, Stein, Harald, Eich, Hans Theodor, Müller, Rolf-Peter, Dietlein, Markus, Borchmann, Peter und Diehl, Volker
(2012)
Reduced-intensity chemotherapy and PET-guided radiotherapy in patients with advanced stage Hodgkin's lymphoma (HD15 trial): a randomised, open-label, phase 3 non-inferiority trial.
The Lancet 379 (9828), S. 1791-1799.
Volltext nicht vorhanden.
2011
d'Amore, Francesco, da Silva, Maria Gomes, Leppa, Sirpa , Relander, Thomas, Pezzutto, Antonio, Lauritzsen, Grete F., Weidmann, Eckhart, Van Gelder, Michel, Merup, Mats, Hagberg, Hans, Fagerli, Unn-Merete, Brown, Peter de Nully, Hansen, Per Boye, Mariz, Jose Mario, Jankovska, Milada, Walewski, Jan, Doorduijn, Jeanette, Van Hoof, Achiel, Christiansen, Ilse, Jyrkkiö, Sirkku, Kluin-Nelemans, J.C., van Marwijk Kooy, Marinus, Fijnheer, Rob, Stevens, Wendy, Zijlstra, Josee, Böhmer, L., Lugtenburg, P.J., Grube, Matthias, Prochazka, Vit, Salek, David, Greil, Richard , Trümper, Lorenz, Wulf, Gerald, Altmann, Bettina, Ziepert, Marita, Loeffler, Markus, Jantunen, Esa, Hopfinger, Georg, Neste, Eric Van den und Toldbod, Helle
(2011)
First Interim Safety Analysis of a Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant,.
Blood 118 (21), S. 4110.
Volltext nicht vorhanden.
, Relander, Thomas, Pezzutto, Antonio, Lauritzsen, Grete F., Weidmann, Eckhart, Van Gelder, Michel, Merup, Mats, Hagberg, Hans, Fagerli, Unn-Merete, Brown, Peter de Nully, Hansen, Per Boye, Mariz, Jose Mario, Jankovska, Milada, Walewski, Jan, Doorduijn, Jeanette, Van Hoof, Achiel, Christiansen, Ilse, Jyrkkiö, Sirkku, Kluin-Nelemans, J.C., van Marwijk Kooy, Marinus, Fijnheer, Rob, Stevens, Wendy, Zijlstra, Josee, Böhmer, L., Lugtenburg, P.J., Grube, Matthias, Prochazka, Vit, Salek, David, Greil, Richard , Trümper, Lorenz, Wulf, Gerald, Altmann, Bettina, Ziepert, Marita, Loeffler, Markus, Jantunen, Esa, Hopfinger, Georg, Neste, Eric Van den und Toldbod, Helle
(2011)
First Interim Safety Analysis of a Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma Treated with CHOP Chemotherapy with or without Alemtuzumab and Consolidated by Autologous Hematopoietic Stem Cell Transplant,.
Blood 118 (21), S. 4110.
Volltext nicht vorhanden.